- Home
- RITR vs TKNO Comparison
RITR vs TKNO Comparison
Compare RITR & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RITR
- TKNO
- Stock Information
- Founded
- RITR 2015
- TKNO 1996
- Country
- RITR Hong Kong
- TKNO United States
- Employees
- RITR N/A
- TKNO N/A
- Industry
- RITR
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- RITR
- TKNO Health Care
- Exchange
- RITR NYSE
- TKNO Nasdaq
- Market Cap
- RITR 249.8M
- TKNO 244.7M
- IPO Year
- RITR 2024
- TKNO 2021
- Fundamental
- Price
- RITR $4.60
- TKNO $7.28
- Analyst Decision
- RITR
- TKNO Buy
- Analyst Count
- RITR 0
- TKNO 2
- Target Price
- RITR N/A
- TKNO $5.00
- AVG Volume (30 Days)
- RITR 186.8K
- TKNO 301.1K
- Earning Date
- RITR 11-26-2024
- TKNO 11-07-2024
- Dividend Yield
- RITR N/A
- TKNO N/A
- EPS Growth
- RITR N/A
- TKNO N/A
- EPS
- RITR 0.04
- TKNO N/A
- Revenue
- RITR $32,198,033.00
- TKNO $36,347,000.00
- Revenue This Year
- RITR N/A
- TKNO $3.56
- Revenue Next Year
- RITR N/A
- TKNO $13.31
- P/E Ratio
- RITR $108.84
- TKNO N/A
- Revenue Growth
- RITR 74.80
- TKNO N/A
- 52 Week Low
- RITR $3.30
- TKNO $1.16
- 52 Week High
- RITR $8.75
- TKNO $8.36
- Technical
- Relative Strength Index (RSI)
- RITR N/A
- TKNO 57.30
- Support Level
- RITR N/A
- TKNO $6.15
- Resistance Level
- RITR N/A
- TKNO $8.36
- Average True Range (ATR)
- RITR 0.00
- TKNO 0.81
- MACD
- RITR 0.00
- TKNO -0.02
- Stochastic Oscillator
- RITR 0.00
- TKNO 60.29
About RITR REITAR LOGTECH HLDGS LTD
Reitar Logtech Holdings Ltd provide one-stop solutions for logistics property operations in property development and redevelopment projects. It consists of two segments: construction management and engineering design services; and asset management and professional consultancy services in Hong Kong. Key revenue is generated from construction management and engineering design services.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.